Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Subregional neuroanatomical change as a biomarker for Alzheimer's disease.

Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20954-9. Erratum in: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6551. Fenema-Notestine, Christine [corrected to Fennema-Notestine, Christine].

2.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, B├╝rger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
3.

The efficacy of a voxel-based morphometry on the analysis of imaging in schizophrenia, temporal lobe epilepsy, and Alzheimer's disease/mild cognitive impairment: a review.

Kakeda S, Korogi Y.

Neuroradiology. 2010 Aug;52(8):711-21. doi: 10.1007/s00234-010-0717-2. Epub 2010 May 22. Review.

PMID:
20495793
4.

Structural neuroimaging in the detection and prognosis of pre-clinical and early AD.

Fennema-Notestine C, McEvoy LK, Hagler DJ Jr, Jacobson MW, Dale AM; The Alzheimer's Disease Neuroimaging Initiative.

Behav Neurol. 2009;21(1):3-12. doi: 10.3233/BEN-2009-0230. Review.

Supplemental Content

Support Center